Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2026-06-03 17:34:36 ET · period of report 2026-06-01 · accession 0000874015-26-000188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-03 17:34 | 2026-06-01 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $24.42 | +8,000 | 164.0K | +5% | +$195.4K |
| DT | 2026-06-03 17:34 | 2026-06-01 | IONS | BERTHELSEN SPENCER R | Dir | S - Sale+OE | $75.67 | -8,000 | 156.0K | -5% | -$605.4K |
| DT | 2026-06-03 17:34 | 2026-06-01 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $0.00 | -8,000 | 8,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 8,000 | $24.42 | 164,013 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-01 | S | D | 8,000 | $75.67 | 156,013 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-06-01 | M | D | 8,000 | $0.00 | 8,000 | D | $24.42 · 2017-07-01 to 2026-06-30 | 8,000 Common Stock |